Zoetis Remains A Strong Buy Following Market Overreaction To Q3 Earnings (NYSE:ZTS)
Zoetis Inc. ( ZTS ) is a pharmaceutical/biotech company that specializes in developing and commercializing various treatments for animals. They were founded in 1952 and are headquartered in Parsippany, NJ. The company IPO’d in 2013 after beingI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I ...